TwongStocks
$INDP 10-Q filed
https://www.sec.gov/Archives/edgar/data/1857044/000149315226051550/form10-q.htm
• 153,602,583 shares outstanding as of Nov 13.
• As of September 30, 2026, had cash of $26.6M & short-term investments of $4.0M. Management believes that existing cash and short-term investments, together with the $3.5M received in October 2026, will be sufficient to fund the Company’s operating expenses and capital expenditure requirements through the year ended December 31, 2027.
• See screenshot for current clinical updates.
• Net loss last quarter was ($1.05M).

:format(webp)/https%3A%2F%2Fst-everywhere-cms-prod.s3.us-east-1.amazonaws.com%2Flarge_kodiak_sciences_c0959a8b8e.jpg)
:format(webp)/https%3A%2F%2Fst-everywhere-cms-prod.s3.us-east-1.amazonaws.com%2Flarge_mrna_100157676a.jpg)